SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital
Descripción del Articulo
        Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PP...
              
            
    
                        | Autores: | , , , | 
|---|---|
| Formato: | artículo | 
| Fecha de Publicación: | 2022 | 
| Institución: | Colegio Médico del Perú | 
| Repositorio: | Acta Médica Peruana | 
| Lenguaje: | español | 
| OAI Identifier: | oai:ojs.pkp.sfu.ca:article/2033 | 
| Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/2033 | 
| Nivel de acceso: | acceso abierto | 
| Materia: | Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption  | 
| id | 
                  REVCMP_8ba40a028b43e6c47e36941aa7f2053c | 
    
|---|---|
| oai_identifier_str | 
                  oai:ojs.pkp.sfu.ca:article/2033 | 
    
| network_acronym_str | 
                  REVCMP | 
    
| network_name_str | 
                  Acta Médica Peruana | 
    
| repository_id_str | 
                  . | 
    
| spelling | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospitalÍndice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de alturaMarmanillo Mendoza, GabrielaZuñiga Manrique, Rosario Elsa JesúsCornejo Del Valle, Oscar EduardoPortilla Canqui, Luis AlbertoCovid-19Hospital MortalityPrecctive Value of TestsSeverity of Illness IndexOxygen ConsumptionObjective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value.Objetivo: comparar el índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura. Materiales y métodos: estudio observacional, retrospectivo y transversal, donde se compararon la sensibilidad (S), especificidad (E), valor predictivo positivo (VPP) y valor predictivo negativo (VPN) de ambos índices. Resultados: La edad promedio de los pacientes con COVID-19 fue 62.2 ±12.8 años, el 73.7% fueron varones, las comorbilidades de mayor frecuencia fueron la diabetes mellitus (21.6%) y la hipertensión arterial (27.2%). Por otro lado el índice promedio SatO2/FiO2 fue 234.9 ±121.9 y el PaO2/FiO2 fue 169.7 ± 84 y el 30.5% de pacientes falleció. Se evidenció relación significativa entre los índices en mención y la mortalidad. Se obtuvo como puntos de corte 114.4 para SatO2/FiO2, con sensibilidad de 43.1%, especificidad de 91.2%, valor predictivo positivo de 68.3% y valor predictivo negativo de 78.5%, mientras que el punto de corte para PaO2/FiO2 fue 134.2, con sensibilidad de 63.1%, especificidad de 67.6%, valor predictivo positivo de 46.1% y valor predictivo negativo de 80.7%. Conclusión: Ambos índices son predictores de mortalidad, sin embargo el SatO2/FiO2 presentó mejores valores, con respecto a algunos de los criterios de sensibilidad, especificidad, valor predictivo positivo y valor predictivo negativo.Colegio Médico del Perú2022-02-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/203310.35663/amp.2021.384.2033ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - DecemberACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421Copyright (c) 2022 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/20332023-07-06T05:49:43Z | 
    
| dc.title.none.fl_str_mv | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital Índice SatO2/FiO2 versus PaO2/FiO2 para predecir mortalidad en pacientes con COVID-19 en un hospital de altura  | 
    
| title | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| spellingShingle | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital Marmanillo Mendoza, Gabriela Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption  | 
    
| title_short | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| title_full | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| title_fullStr | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| title_full_unstemmed | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| title_sort | 
                  SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital | 
    
| dc.creator.none.fl_str_mv | 
                  Marmanillo Mendoza, Gabriela Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto  | 
    
| author | 
                  Marmanillo Mendoza, Gabriela | 
    
| author_facet | 
                  Marmanillo Mendoza, Gabriela Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto  | 
    
| author_role | 
                  author | 
    
| author2 | 
                  Zuñiga Manrique, Rosario Elsa Jesús Cornejo Del Valle, Oscar Eduardo Portilla Canqui, Luis Alberto  | 
    
| author2_role | 
                  author author author  | 
    
| dc.subject.none.fl_str_mv | 
                  Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption  | 
    
| topic | 
                  Covid-19 Hospital Mortality Precctive Value of Tests Severity of Illness Index Oxygen Consumption  | 
    
| description | 
                  Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and methods: This is an observational, retrospective, and cross-sectional study, where sensitivity(S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value. | 
    
| publishDate | 
                  2022 | 
    
| dc.date.none.fl_str_mv | 
                  2022-02-04 | 
    
| dc.type.none.fl_str_mv | 
                  info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion  | 
    
| format | 
                  article | 
    
| status_str | 
                  publishedVersion | 
    
| dc.identifier.none.fl_str_mv | 
                  https://amp.cmp.org.pe/index.php/AMP/article/view/2033 10.35663/amp.2021.384.2033  | 
    
| url | 
                  https://amp.cmp.org.pe/index.php/AMP/article/view/2033 | 
    
| identifier_str_mv | 
                  10.35663/amp.2021.384.2033 | 
    
| dc.language.none.fl_str_mv | 
                  spa | 
    
| language | 
                  spa | 
    
| dc.relation.none.fl_str_mv | 
                  https://amp.cmp.org.pe/index.php/AMP/article/view/2033/1421 | 
    
| dc.rights.none.fl_str_mv | 
                  Copyright (c) 2022 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess  | 
    
| rights_invalid_str_mv | 
                  Copyright (c) 2022 ACTA MEDICA PERUANA | 
    
| eu_rights_str_mv | 
                  openAccess | 
    
| dc.format.none.fl_str_mv | 
                  application/pdf | 
    
| dc.publisher.none.fl_str_mv | 
                  Colegio Médico del Perú | 
    
| publisher.none.fl_str_mv | 
                  Colegio Médico del Perú | 
    
| dc.source.none.fl_str_mv | 
                  ACTA MEDICA PERUANA; Vol 38 No 4 (2021): October - December ACTA MEDICA PERUANA; Vol. 38 Núm. 4 (2021): Octubre - Diciembre 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP  | 
    
| instname_str | 
                  Colegio Médico del Perú | 
    
| instacron_str | 
                  CMP | 
    
| institution | 
                  CMP | 
    
| reponame_str | 
                  Acta Médica Peruana | 
    
| collection | 
                  Acta Médica Peruana | 
    
| repository.name.fl_str_mv | 
                   | 
    
| repository.mail.fl_str_mv | 
                   | 
    
| _version_ | 
                  1816075110988120064 | 
    
| score | 
                  13.977305 | 
    
 Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
    La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).